ABSTRACT
Understanding cortical movement representations and their stability can shed light on robust brain-machine interface (BMI) approaches to decode these representations without frequent recalibration. Here, we characterize the spatial organization (somatotopy) and stability of the bilateral sensorimotor map of forearm muscles in an incomplete-high spinal-cord injury study participant implanted bilaterally in the primary motor and sensory cortices with Utah microelectrode arrays (MEAs).
We built the map by recording multiunit activity (MUA) and surface electromyography (EMG) as the participant executed (or attempted) contractions of 2 wrist muscles on each side of the body. To assess stability, we repeatedly mapped and compared left--wrist--extensor-related activity throughout several sessions, comparing somatotopy of active electrodes and neural signals both at the within-electrode (multiunit) and cross-electrode (network) levels.
Body maps showed significant activation in motor and sensory cortical electrodes, with fractured, intermixed representations of both intact and paralytic muscles. Within electrodes, firing strength stability decreased with time, with higher stability observed in sensory cortex than in motor, and in the contralateral hemisphere than in the ipsilateral. However, we observed no differences at network level, and no evidence of decoding instabilities for wrist EMG, either across timespans of hours or days, or across recording area. These results demonstrate first-time construction of a bilateral human sensorimotor map with MEAs. Further, while map stability differs between brain area and hemisphere at multiunit/electrode level, these differences are nullified at ensemble level.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03161067
Funding Statement
This research was supported by the following funding: the Defense Advanced Research Projects Agency (DARPA, Arlington) Revolutionizing Prosthetics program (contract N6600110C4056) and Neurally-Enhanced Operations program (contract HR001120C0120); the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) T32HD741426 (RWN); and the National Institute of Neurological Disorders and Stroke (NIH-NINDS) NS088606 (TMT, DNC, NEC). The views, opinions, and/or findings expressed are those of the author(s) and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. Development of experimental setup and support for regulatory submissions associated with this study were provided by a grant from the Alfred E. Mann Foundation. Software infrastructure and study preparation were developed with internal funding from Johns Hopkins University Applied Physics Laboratory and the Johns Hopkins School of Medicine.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted under an Investigational Device Exemption (IDE) by the FDA (G170010) and approved by the Johns Hopkins School of Medicine and NIWC Pacific Institutional Review Boards (IRBs)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data for this preprint is not publicly available at this time.
